Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
How are triggers for telogen effluvium investigated?
Diffuse shedding may appear after a delay following illness, fever, surgery, childbirth, rapid weight change, nutritional deficiency, medicines or psychological stress. Hair loss is not one diagnosis; no standard procedure plan can be set before cause, scalp findings and systemic factors are assessed.
This translation has no recorded clinical or medical-language review.
Direct answer
- Diffuse shedding may appear after a delay following illness, fever, surgery, childbirth, rapid weight change, nutritional deficiency, medicines or psychological stress.
- Hair loss is not one diagnosis; no standard procedure plan can be set before cause, scalp findings and systemic factors are assessed.
- Discuss the timeline, recent events, menstrual and nutritional history, medicines, scalp symptoms and appropriate medical tests.
Assessment framework
Diffuse shedding may appear after a delay following illness, fever, surgery, childbirth, rapid weight change, nutritional deficiency, medicines or psychological stress. Hair loss is not one diagnosis; no standard procedure plan can be set before cause, scalp findings and systemic factors are assessed. This information is not a diagnosis, prescription, personal suitability decision or fixed procedure plan.
Questions for consultation
Discuss the timeline, recent events, menstrual and nutritional history, medicines, scalp symptoms and appropriate medical tests. Alternatives, the option of no procedure, material risks, follow-up and urgent warning signs should also be discussed individually.
Sources and evidence limits
These links are editorial starting points used to examine the article's boundaries.
- Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venereology
S. Vañó-Galván et al.; Spanish Hair Disorders Research Group · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
- Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials
L. Kieling, A. T. Konzen, R. K. Zanella and D. S. Valente · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
- Systematic review of mesotherapy: a novel avenue for the treatment of hair loss
A. K. Gupta, S. Polla Ravi, T. Wang, M. Talukder, M. Starace and B. M. Piraccini · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review